Literature DB >> 22851771

Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.

Siver Andreas Moestue, Guro F Giskeødegård, Maria D Cao, Tone F Bathen, Ingrid S Gribbestad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22851771      PMCID： PMC3458347          DOI： 10.1073/pnas.1208226109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.

Authors:  Guro F Giskeødegård; Maria T Grinde; Beathe Sitter; David E Axelson; Steinar Lundgren; Hans E Fjøsne; Steinar Dahl; Ingrid S Gribbestad; Tone F Bathen
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

2.  Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.

Authors:  Maria D Cao; Beathe Sitter; Tone F Bathen; Anna Bofin; Per E Lønning; Steinar Lundgren; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-08-08       Impact factor: 4.044

3.  Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.

Authors:  Joanna D Stewart; Rosemarie Marchan; Michaela S Lesjak; Joerg Lambert; Roland Hergenroeder; James K Ellis; Chung-Ho Lau; Hector C Keun; Gerd Schmitz; Juergen Schiller; Mandy Eibisch; Christian Hedberg; Herbert Waldmann; Ekkehart Lausch; Berno Tanner; Jalid Sehouli; Jens Sagemueller; Hagen Staude; Eric Steiner; Jan G Hengstler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-08       Impact factor: 11.205

4.  Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.

Authors:  Siver A Moestue; Eldrid Borgan; Else M Huuse; Evita M Lindholm; Beathe Sitter; Anne-Lise Børresen-Dale; Olav Engebraaten; Gunhild M Maelandsmo; Ingrid S Gribbestad
Journal:  BMC Cancer       Date:  2010-08-17       Impact factor: 4.430

5.  Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.

Authors:  Maria D Cao; Guro F Giskeødegård; Tone F Bathen; Beathe Sitter; Anna Bofin; Per E Lønning; Steinar Lundgren; Ingrid S Gribbestad
Journal:  BMC Cancer       Date:  2012-01-25       Impact factor: 4.430
  5 in total
  13 in total

1.  Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.

Authors:  J P Wijnen; L Jiang; T R Greenwood; M Cheng; M Döpkens; M D Cao; Z M Bhujwalla; B Krishnamachary; D W J Klomp; K Glunde
Journal:  NMR Biomed       Date:  2014-04-24       Impact factor: 4.044

2.  CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.

Authors:  Kannie W Y Chan; Lu Jiang; Menglin Cheng; Jannie P Wijnen; Guanshu Liu; Peng Huang; Peter C M van Zijl; Michael T McMahon; Kristine Glunde
Journal:  NMR Biomed       Date:  2016-04-21       Impact factor: 4.044

3.  Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.

Authors:  Guro F Giskeødegård; Helena Bertilsson; Kirsten M Selnæs; Alan J Wright; Tone F Bathen; Trond Viset; Jostein Halgunset; Anders Angelsen; Ingrid S Gribbestad; May-Britt Tessem
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

4.  Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.

Authors:  Rosemarie Marchan; Michaela S Lesjak; Joanna D Stewart; Roland Winter; Janine Seeliger; Jan G Hengstler
Journal:  Cell Cycle       Date:  2012-10-31       Impact factor: 4.534

5.  Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR Metabolomics.

Authors:  Ju Feng; Nancy G Isern; Sarah D Burton; Jian Zhi Hu
Journal:  Metabolites       Date:  2013-10-31

6.  Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.

Authors:  Maria T Grinde; Nirma Skrbo; Siver A Moestue; Einar A Rødland; Eldrid Borgan; Alexandr Kristian; Beathe Sitter; Tone F Bathen; Anne-Lise Børresen-Dale; Gunhild M Mælandsmo; Olav Engebraaten; Therese Sørlie; Elisabetta Marangoni; Ingrid S Gribbestad
Journal:  Breast Cancer Res       Date:  2014-01-21       Impact factor: 6.466

7.  Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3.

Authors:  Su M Phyu; Chih-Chung Tseng; Ian N Fleming; Tim A D Smith
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

8.  Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism.

Authors:  Tim A D Smith; Su M Phyu; Kholoud S Alzyoud; Chih-Chung Tseng
Journal:  Biomed Res Int       Date:  2017-06-22       Impact factor: 3.411

9.  Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.

Authors:  Siver A Moestue; Cornelia G Dam; Saurabh S Gorad; Alexandr Kristian; Anna Bofin; Gunhild M Mælandsmo; Olav Engebråten; Ingrid S Gribbestad; Geir Bjørkøy
Journal:  Breast Cancer Res       Date:  2013-02-28       Impact factor: 6.466

10.  Metabolite Signatures in Hydrophilic Extracts of Mouse Lungs Exposed to Cigarette Smoke Revealed by 1H NMR Metabolomics Investigation.

Authors:  Hu Jz; Wang X; Feng J; Robertson Bj; Waters Km; Tilton Sc; Pounds Jg; Corley Ra; Liu M; Hu M
Journal:  Metabolomics (Los Angel)       Date:  2015-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.